Anti-BMP1/ OI13/ PCOLC functional antibody
Anti-BMP1/ OI13/ PCOLC functional antibody for cell culture, ELISA & in-vivo assay
Go to BMP1/BMP1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-T53350-Ab-1/ GM-Tg-hg-T53350-Ab-2 | Anti-Human BMP1 monoclonal antibody | Human |
GM-Tg-rg-T53350-Ab-1/ GM-Tg-rg-T53350-Ab-2 | Anti-Rat BMP1 monoclonal antibody | Rat |
GM-Tg-mg-T53350-Ab-1/ GM-Tg-mg-T53350-Ab-2 | Anti-Mouse BMP1 monoclonal antibody | Mouse |
GM-Tg-cynog-T53350-Ab-1/ GM-Tg-cynog-T53350-Ab-2 | Anti-Cynomolgus/ Rhesus macaque BMP1 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-T53350-Ab-1/ GM-Tg-felg-T53350-Ab-2 | Anti-Feline BMP1 monoclonal antibody | Feline |
GM-Tg-cang-T53350-Ab-1/ GM-Tg-cang-T53350-Ab-2 | Anti-Canine BMP1 monoclonal antibody | Canine |
GM-Tg-bovg-T53350-Ab-1/ GM-Tg-bovg-T53350-Ab-2 | Anti-Bovine BMP1 monoclonal antibody | Bovine |
GM-Tg-equg-T53350-Ab-1/ GM-Tg-equg-T53350-Ab-2 | Anti-Equine BMP1 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-T53350-Ab-1/ GM-Tg-hg-T53350-Ab-2; GM-Tg-rg-T53350-Ab-1/ GM-Tg-rg-T53350-Ab-2; GM-Tg-mg-T53350-Ab-1/ GM-Tg-mg-T53350-Ab-2; GM-Tg-cynog-T53350-Ab-1/ GM-Tg-cynog-T53350-Ab-2; GM-Tg-felg-T53350-Ab-1/ GM-Tg-felg-T53350-Ab-2; GM-Tg-cang-T53350-Ab-1/ GM-Tg-cang-T53350-Ab-2; GM-Tg-bovg-T53350-Ab-1/ GM-Tg-bovg-T53350-Ab-2; GM-Tg-equg-T53350-Ab-1/ GM-Tg-equg-T53350-Ab-2 |
Products Name | Anti-BMP1 monoclonal antibody |
Format | mab |
Target Name | BMP1 |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category of antibody | FACS/Biofunctional Antibody, Therapeutics Target antibody, Cytokine antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-BMP1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-T53350-Ag-1 | Recombinant multi-species BMP1/ OI13/ PCOLC protein |
Cytokine | GM-Tg-g-T53350-Ag-1 | bone morphogenetic protein 1 (BMP1) protein |
Target information
Target ID | GM-T53350 |
Target Name | BMP1 |
Gene ID | 649,12153,83470,707596,100856514,101093350,510360,100056914 |
Gene Symbol and Synonyms | BMP1,OI13,PCOLC,PCP,PCP2,TLD |
Uniprot Accession | P13497 |
Uniprot Entry Name | BMP1_HUMAN |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category | Therapeutics Target, Cytokine Target |
Disease | Lung Cancer, Dent disease |
Gene Ensembl | ENSG00000168487 |
Target Classification | N/A |
The target: BMP1, gene name: BMP1, also named as OI13, PCOLC, PCP, PCP2, TLD. This gene encodes a protein that is capable of inducing formation of cartilage in vivo. Although other bone morphogenetic proteins are members of the TGF-beta superfamily, this gene encodes a protein that is not closely related to other known growth factors. This gene is expressed as alternatively spliced variants that share an N-terminal protease domain but differ in their C-terminal region. [provided by RefSeq, Aug 2008].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.